BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, March 6, 2026
Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Questcor Raises $5M To Fund $18.2M Purchase Of Nascobal

June 18, 2003
By Aaron Lorenzo

Cytogen Regains Rights To Berlex's Cancer Pain Product

June 17, 2003
By Aaron Lorenzo

ICOS Planning To Raise $250M Through Private Sale Of Notes

June 17, 2003
By Aaron Lorenzo
ICOS Corp. is looking to raise $250 million through an offering of convertible subordinated notes. (BioWorld Today)
Read More

Cytogen Regains Rights To Berlex's Cancer Pain Product

June 17, 2003
By Aaron Lorenzo

ICOS Planning To Raise $250M Through Private Sale Of Notes

June 17, 2003
By Aaron Lorenzo
ICOS Corp. is looking to raise $250 million through an offering of convertible subordinated notes. (BioWorld Today)
Read More

Exelixis Plans To Sell 10 Million Shares Through Public Offering

June 16, 2003
By Aaron Lorenzo

Exelixis Plans To Sell 10 Million Shares Through Public Offering

June 16, 2003
By Aaron Lorenzo

Pozen Licenses Migraine Drug To GSK In Potential $160M Deal

June 13, 2003
By Aaron Lorenzo
Pozen Inc. could garner up to at least $160 million after entering a deal with GlaxoSmithKline plc surrounding a migraine treatment. (BioWorld Today)
Read More

Pozen Licenses Migraine Drug To GSK In Potential $160M Deal

June 13, 2003
By Aaron Lorenzo
Pozen Inc. could garner up to at least $160 million after entering a deal with GlaxoSmithKline plc surrounding a migraine treatment. (BioWorld Today)
Read More

NPS Planning To Sell $125M In Notes After Merger Talks End

June 12, 2003
By Aaron Lorenzo
Previous 1 2 … 187 188 189 190 191 192 193 194 195 … 237 238 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 5, 2026.
  • Brain and virus with chromosome

    CROI 2026: Neurodegeneration, the challenge of aging with HIV

    BioWorld
    Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
  • Depression concept with human, broken brain and heavy rain

    CROI 2026 highlights depression and cognitive vulnerability in HIV

    BioWorld
    The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 3, 2026
  • Concept art for headache

    Slate Medicines launches with focus on headache disorders

    BioWorld Science
    Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing